Guru Fundamental Report for JNJ

Johnson & Johnson (JNJ) received a 77% rating from Validea's P/B Growth Investor model, which is based on Partha Mohanram's academically-derived strategy known for identifying sustained growth in low book-to-market stocks and historical market outperformance. While JNJ passed most of the model's criteria, including key asset and cash flow metrics, its score falls just below the 80% threshold for "some interest," notably failing tests related to advertising and research & development expenditures relative to assets. This indicates JNJ exhibits many growth characteristics but presents specific areas of concern under this rigorous framework.

Analysis

Johnson & Johnson (JNJ) scores a 77% on Validea's P/B Growth Investor model, a framework developed by Partha Mohanram to identify low book-to-market stocks with sustained growth potential. This rating is moderately positive but remains just below the 80% threshold that typically signals active interest from the strategy. The analysis reveals a company with strong underlying fundamentals, passing key tests for Return on Assets, Cash Flow from Operations to Assets, and stability in both ROA and sales variance. These passes indicate a financially healthy and operationally stable enterprise. However, the model flags two critical weaknesses for a growth-oriented stock: JNJ fails the criteria for both Advertising to Assets and Research and Development to Assets. For a large-cap firm in the Biotechnology & Drugs industry, these failures suggest that its investment in future growth drivers, such as marketing and innovation, is considered insufficient by this specific academic model, creating a dichotomy between its current financial strength and its potential for future top-line acceleration.

Key Decisions for Investors

• Investors seeking pure growth might view the failure on R&D and advertising metrics as a red flag, warranting a deeper dive into JNJ's product pipeline and competitive positioning before initiating or adding to a position.
• For value-oriented or GARP (Growth at a Reasonable Price) investors, the strong performance on cash flow, asset returns, and stability metrics could be attractive, suggesting JNJ is a high-quality company that may be overlooked by aggressive growth screens.
• Monitor future quarterly reports for any significant shifts in R&D and advertising expenditures as a percentage of assets, as an increase could signal a strategic pivot towards accelerating growth and trigger a higher rating from this model.
• Given the mixed signals, investors could consider JNJ a core holding for stability but may want to look elsewhere for alpha generation driven by high-growth characteristics.